Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol.

Basu, A; Caumo, A; Bettini, F; Gelisio, A; Alzaid, A; Cobelli, C; Rizza, R A

Basu, A; Caumo, A; Bettini, F; Gelisio, A; Alzaid, A; Cobelli, C; Rizza, R A.

Affiliation

Basu A; Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.

Diabetes ; 46(3): 421-32, 1997 Mar.

Article in En | MEDLINE | ID: mdl-9032098

Subject(s)

Blood Glucose/metabolism; Diabetes Mellitus, Type 2/metabolism; Glucose/metabolism; Insulin/pharmacology; Models, Biological; Blood Glucose/drug effects; Diabetes Mellitus, Type 2/blood; Fatty Acids, Nonesterified/blood; Female; Glucagon/blood; Glycolysis; Human Growth Hormone/blood; Humans; Insulin/administration & dosage; Insulin/blood; Kinetics; Male; Mathematics; Middle Aged; Reference Values; Somatostatin/blood

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Diabetes Mellitus, Type 2 / Glucose / Insulin / Models, Biological Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabetes Year: 1997 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links